TreeWAS – Variant ID: rs10744775

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E03.9 Hypothyroidism, unspecified	0.000	0.000	1.000
E03 Other hypothyroidism	0.000	0.510	0.490
E03.8 Other specified hypothyroidism	0.000	0.607	0.393
E03.2 Hypothyroidism due to medicaments and other exogenous substances	0.000	0.616	0.384
E03.5 Myxoedema coma	0.000	0.648	0.352
E03.4 Atrophy of thyroid (acquired)	0.000	0.648	0.352
E03.3 Postinfectious hypothyroidism	0.000	0.648	0.352
E03.1 Congenital hypothyroidism without goitre	0.000	0.674	0.326
E03.0 Congenital hypothyroidism with diffuse goitre	0.000	0.690	0.310
J34.2 Deviated nasal septum	0.214	0.786	0.000
Z95.0 Presence of cardiac pacemaker	0.000	0.918	0.082
Z95 Presence of cardiac and vascular implants and grafts	0.000	0.921	0.079
Z95.4 Presence of other heart-valve replacement	0.000	0.924	0.076
Z95.5 Presence of coronary angioplasty implant and graft	0.000	0.926	0.074
M35.0 Sicca syndrome [Sjogren]	0.000	0.928	0.072
Z95.2 Presence of prosthetic heart valve	0.000	0.928	0.072
Z95.3 Presence of xenogenic heart valve	0.000	0.935	0.065
J34 Other disorders of nose and nasal sinuses	0.064	0.936	0.000
J34.3 Hypertrophy of nasal turbinates	0.061	0.939	0.000
Z95.9 Presence of cardiac and vascular implant and graft, unspecified	0.000	0.945	0.055
E00-E07 Disorders of thyroid gland	0.000	0.949	0.051
C84 Peripheral and cutaneous T-cell lymphomas	0.046	0.954	0.000
C90.0 Multiple myeloma	0.046	0.954	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.045	0.955	0.000
C77.3 Axillary and upper limb lymph nodes	0.045	0.955	0.000
Z95.8 Presence of other cardiac and vascular implants and grafts	0.000	0.956	0.044
C84.5 Other and unspecified T-cell lymphomas	0.044	0.956	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.043	0.957	0.000
C84.4 Peripheral T-cell lymphoma	0.041	0.959	0.000
C84.0 Mycosis fungoides	0.041	0.959	0.000
C49.3 Connective and soft tissue of thorax	0.040	0.960	0.000
C49 Malignant neoplasm of other connective and soft tissue	0.040	0.960	0.000
J34.0 Abscess, furuncle and carbuncle of nose	0.039	0.961	0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.039	0.961	0.000
C95 Leukaemia of unspecified cell type	0.038	0.962	0.000
E02 Subclinical iodine-deficiency hypothyroidism	0.000	0.962	0.038
C90.2 Plasmacytoma, extramedullary	0.037	0.963	0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.963	0.036
E00 Congenital iodine-deficiency syndrome	0.000	0.963	0.036
C84.8 Cutaneous T-cell lymphoma, unspecified	0.036	0.964	0.000
C45 Mesothelioma	0.036	0.964	0.000
E06 Thyroiditis	0.000	0.964	0.036
C34 Malignant neoplasm of bronchus and lung	0.035	0.965	0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.035	0.965	0.000
C90.1 Plasma cell leukaemia	0.034	0.966	0.000
C49.9 Connective and soft tissue, unspecified	0.034	0.966	0.000
Chapter II Neoplasms	0.034	0.966	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.034	0.966	0.000
C49.5 Connective and soft tissue of pelvis	0.033	0.967	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.033	0.967	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.033	0.967	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.033	0.967	0.000
C84.3 Lymphoepithelioid lymphoma	0.033	0.967	0.000
C84.2 T-zone lymphoma	0.033	0.967	0.000
C84.1 Sezary's diease	0.033	0.967	0.000
C81 Hodgkin's disease	0.033	0.967	0.000
C92 Myeloid leukaemia	0.033	0.967	0.000
C45.0 Mesothelioma of pleura	0.033	0.967	0.000
C34.9 Bronchus or lung, unspecified	0.032	0.968	0.000
C49.1 Connective and soft tissue of upper limb, including shoulder	0.032	0.968	0.000
C95.0 Acute leukaemia of unspecified cell type	0.032	0.968	0.000
C95.9 Leukaemia, unspecified	0.032	0.968	0.000
C34.3 Lower lobe, bronchus or lung	0.032	0.968	0.000
C50-C50 Malignant neoplasm of breast	0.032	0.968	0.000
C34.1 Upper lobe, bronchus or lung	0.031	0.969	0.000
J34.1 Cyst and mucocele of nose and nasal sinus	0.031	0.969	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.031	0.969	0.000
C94 Other leukaemias of specified cell type	0.031	0.969	0.000
C86 Other specified types of T/NK-cell lymphoma	0.031	0.969	0.000
E07 Other disorders of thyroid	0.000	0.969	0.031
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system	0.030	0.970	0.000
C50 Malignant neoplasm of breast	0.030	0.970	0.000
C90.3 Solitary plasmacytoma	0.030	0.970	0.000
C93 Monocytic leukaemia	0.030	0.970	0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.030	0.970	0.000
C45.7 Mesothelioma of other sites	0.030	0.970	0.000
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.030	0.970	0.000
C50.8 Overlapping lesion of breast	0.029	0.971	0.000
C49.8 Overlapping lesion of connective and soft tissue	0.029	0.971	0.000
C49.6 Connective and soft tissue of trunk, unspecified	0.029	0.971	0.000
C81.2 Mixed cellularity	0.029	0.971	0.000
C49.4 Connective and soft tissue of abdomen	0.029	0.971	0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites	0.028	0.972	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.028	0.972	0.000
E06.9 Thyroiditis, unspecified	0.000	0.972	0.028
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.028	0.972	0.000
C46 Kaposi's sarcoma	0.028	0.972	0.000
C88 Malignant immunoproliferative diseases	0.028	0.972	0.000
C31 Malignant neoplasm of accessory sinuses	0.028	0.972	0.000
C82.0 Small cleaved cell, follicular	0.028	0.972	0.000
C64-C68 Malignant neoplasms of urinary tract	0.028	0.972	0.000
C82.2 Large cell, follicular	0.028	0.972	0.000
C95.7 Other leukaemia of unspecified cell type	0.027	0.972	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.027	0.972	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.027	0.972	0.000
C45.9 Mesothelioma, unspecified	0.027	0.972	0.000
C69 Malignant neoplasm of eye and adnexa	0.028	0.972	0.000
C64 Malignant neoplasm of kidney, except renal pelvis	0.027	0.973	0.000
C50.1 Central portion of breast	0.027	0.973	0.000
C97 Malignant neoplasms of independent (primary) multiple sites	0.027	0.973	0.000
C77.4 Inguinal and lower limb lymph nodes	0.027	0.973	0.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.027	0.973	0.000
C34.8 Overlapping lesion of bronchus and lung	0.026	0.974	0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified	0.000	0.974	0.026
E00.2 Congenital iodine-deficiency syndrome, mixed type	0.000	0.974	0.026
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type	0.000	0.974	0.026
E00.0 Congenital iodine-deficiency syndrome, neurological type	0.000	0.974	0.026
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions	0.000	0.974	0.026
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified	0.000	0.974	0.026
E01.1 Iodine-deficiency-related multinodular (endemic) goitre	0.000	0.974	0.026
E01.0 Iodine-deficiency-related diffuse (endemic) goitre	0.000	0.974	0.026
C34.0 Main bronchus	0.026	0.974	0.000
C50.0 Nipple and areola	0.026	0.974	0.000
C45.2 Mesothelioma of pericardium	0.026	0.974	0.000
C45.1 Mesothelioma of peritoneum	0.026	0.974	0.000
C81.1 Nodular sclerosis	0.026	0.974	0.000
E06.4 Drug-induced thyroiditis	0.000	0.974	0.026
E06.2 Chronic thyroiditis with transient thyrotoxicosis	0.000	0.974	0.026
E06.1 Subacute thyroiditis	0.000	0.974	0.026
E06.0 Acute thyroiditis	0.000	0.974	0.026
C38 Malignant neoplasm of heart, mediastinum and pleura	0.026	0.974	0.000
C40-C41 Malignant neoplasms of bone and articular cartilage	0.026	0.974	0.000
C32 Malignant neoplasm of larynx	0.025	0.975	0.000
C92.0 Acute myeloid leukaemia	0.025	0.975	0.000
C82.4 Follicular lymphoma grade IIIb	0.025	0.975	0.000
C37 Malignant neoplasm of thymus	0.025	0.975	0.000
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.025	0.975	0.000
C33 Malignant neoplasm of trachea	0.025	0.975	0.000
C92.4 Acute promyelocytic leukaemia	0.025	0.975	0.000
E06.5 Other chronic thyroiditis	0.000	0.975	0.025
E06.3 Autoimmune thyroiditis	0.000	0.976	0.024
C82.6 Cutaneous follicle centre lymphoma	0.024	0.976	0.000
C82.5 Diffuse follicle centre lymphoma	0.024	0.976	0.000
C50.4 Upper-outer quadrant of breast	0.024	0.976	0.000
C92.9 Myeloid leukaemia, unspecified	0.024	0.976	0.000
C69.4 Ciliary body	0.024	0.976	0.000
C81.7 Other Hodgkin's disease	0.024	0.976	0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.024	0.976	0.000
C81.3 Lymphocytic depletion	0.024	0.976	0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.024	0.976	0.000
T80.2 Infections following infusion, transfusion and therapeutic injection	0.024	0.976	0.000
C49.2 Connective and soft tissue of lower limb, including hip	0.024	0.976	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.024	0.976	0.000
C92.7 Other myeloid leukaemia	0.024	0.976	0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.024	0.976	0.000
C92.5 Acute myelomonocytic leukaemia	0.024	0.976	0.000
C92.3 Myeloid sarcoma	0.024	0.976	0.000
C92.2 Subacute myeloid leukaemia	0.024	0.976	0.000
T80.1 Vascular complications following infusion, transfusion and therapeutic injection	0.024	0.976	0.000
C50.6 Axillary tail of breast	0.024	0.976	0.000
C31.0 Maxillary sinus	0.023	0.976	0.000
C81.0 Lymphocytic predominance	0.023	0.976	0.000
C48.2 Peritoneum, unspecified	0.023	0.976	0.000
C76 Malignant neoplasm of other and ill-defined sites	0.023	0.976	0.000
C71 Malignant neoplasm of brain	0.023	0.976	0.000
C30 Malignant neoplasm of nasal cavity and middle ear	0.023	0.977	0.000
T80 Complications following infusion, transfusion and therapeutic injection	0.023	0.977	0.000
C48.1 Specified parts of peritoneum	0.023	0.977	0.000
C82.3 Follicular lymphoma grade IIIa	0.023	0.977	0.000
E05 Thyrotoxicosis [hyperthyroidism]	0.000	0.977	0.023
C65 Malignant neoplasm of renal pelvis	0.023	0.977	0.000
C50.9 Breast, unspecified	0.023	0.977	0.000
C69.6 Orbit	0.023	0.977	0.000
C94.7 Other specified leukaemias	0.022	0.977	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.022	0.977	0.000
C94.5 Acute myelofibrosis	0.022	0.977	0.000
C94.4 Acute panmyelosis	0.022	0.977	0.000
C94.3 Mast cell leukaemia	0.022	0.977	0.000
C94.2 Acute megakaryoblastic leukaemia	0.022	0.977	0.000
C94.1 Chronic erythraemia	0.022	0.977	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.022	0.977	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.022	0.977	0.000
C96.8 Histiocytic sarcoma	0.022	0.977	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.022	0.977	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.022	0.977	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.022	0.977	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.022	0.977	0.000
C96.3 True histiocytic lymphoma	0.022	0.977	0.000
C96.2 Malignant mast cell tumour	0.022	0.977	0.000
C96.1 Malignant histiocytosis	0.022	0.977	0.000
C96.0 Letterer-Siwe disease	0.022	0.977	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.022	0.977	0.000
C86.4 Blastic NK-cell lymphoma	0.022	0.977	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.022	0.977	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.022	0.977	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.022	0.977	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.022	0.977	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.022	0.978	0.000
C72 Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system	0.022	0.978	0.000
E07.1 Dyshormogenetic goitre	0.000	0.978	0.022
E07.0 Hypersecretion of calcitonin	0.000	0.978	0.022
C92.1 Chronic myeloid leukaemia	0.022	0.978	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.022	0.978	0.000
C70 Malignant neoplasm of meninges	0.022	0.978	0.000
E07.9 Disorder of thyroid, unspecified	0.000	0.978	0.022
C93.9 Monocytic leukaemia, unspecified	0.022	0.978	0.000
C93.7 Other monocytic leukaemia	0.022	0.978	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.022	0.978	0.000
C93.2 Subacute monocytic leukaemia	0.022	0.978	0.000
C93.0 Acute monocytic leukaemia	0.022	0.978	0.000
C68 Malignant neoplasm of other and unspecified urinary organs	0.022	0.978	0.000
C80 Malignant neoplasm without specification of site	0.022	0.978	0.000
C48.8 Overlapping lesion of retroperitoneum and peritoneum	0.021	0.978	0.000
C41 Malignant neoplasm of bone and articular cartilage of other and unspecified sites	0.021	0.979	0.000
T80.8 Other complications following infusion, transfusion and therapeutic injection	0.021	0.979	0.000
C49.0 Connective and soft tissue of head, face and neck	0.021	0.979	0.000
C69.0 Conjunctiva	0.021	0.979	0.000
C93.1 Chronic monocytic leukaemia	0.020	0.979	0.000
C71.4 Occipital lobe	0.020	0.979	0.000
C46.9 Kaposi's sarcoma, unspecified	0.020	0.979	0.000
C46.8 Kaposi's sarcoma of multiple organs	0.020	0.979	0.000
C46.7 Kaposi's sarcoma of other sites	0.020	0.979	0.000
C46.3 Kaposi's sarcoma of lymph nodes	0.020	0.979	0.000
C46.2 Kaposi's sarcoma of palate	0.020	0.979	0.000
C46.1 Kaposi's sarcoma of soft tissue	0.020	0.979	0.000
C46.0 Kaposi's sarcoma of skin	0.020	0.979	0.000
C47.9 Peripheral nerves and autonomic nervous system, unspecified	0.020	0.979	0.000
C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system	0.020	0.979	0.000
C47.6 Peripheral nerves of trunk, unspecified	0.020	0.979	0.000
C47.5 Peripheral nerves of pelvis	0.020	0.979	0.000
C47.4 Peripheral nerves of abdomen	0.020	0.979	0.000
C47.3 Peripheral nerves of thorax	0.020	0.979	0.000
C47.2 Peripheral nerves of lower limb, including hip	0.020	0.979	0.000
C47.1 Peripheral nerves of upper limb, including shoulder	0.020	0.979	0.000
C47.0 Peripheral nerves of head, face and neck	0.020	0.979	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.020	0.980	0.000
C88.7 Other malignant immunoproliferative diseases	0.020	0.980	0.000
C88.3 Immunoproliferative small intestinal disease	0.020	0.980	0.000
C88.2 Gamma heavy chain disease	0.020	0.980	0.000
C88.1 Alpha heavy chain disease	0.020	0.980	0.000
C31.9 Accessory sinus, unspecified	0.020	0.980	0.000
C31.8 Overlapping lesion of accessory sinuses	0.020	0.980	0.000
C31.3 Sphenoidal sinus	0.020	0.980	0.000
C31.2 Frontal sinus	0.020	0.980	0.000
C31.1 Ethmoidal sinus	0.020	0.980	0.000
C32.9 Larynx, unspecified	0.020	0.980	0.000
C69.9 Eye, unspecified	0.020	0.980	0.000
C69.8 Overlapping lesion of eye and adnexa	0.020	0.980	0.000
C69.5 Lachrymal gland and duct	0.020	0.980	0.000
C69.2 Retina	0.020	0.980	0.000
C69.1 Cornea	0.020	0.980	0.000
C38.4 Pleura	0.020	0.980	0.000
Z95.1 Presence of aortocoronary bypass graft	0.000	0.980	0.020
C76.0 Head, face and neck	0.019	0.980	0.000
C71.1 Frontal lobe	0.020	0.980	0.000
C69.3 Choroid	0.019	0.981	0.000
C77.8 Lymph nodes of multiple regions	0.019	0.981	0.000
C76.1 Thorax	0.019	0.981	0.000
C50.5 Lower-outer quadrant of breast	0.019	0.981	0.000
C32.0 Glottis	0.019	0.981	0.000
C74 Malignant neoplasm of adrenal gland	0.019	0.981	0.000
C38.8 Overlapping lesion of heart, mediastinum and pleura	0.019	0.981	0.000
C38.3 Mediastinum, part unspecified	0.019	0.981	0.000
C38.2 Posterior mediastinum	0.019	0.981	0.000
C38.1 Anterior mediastinum	0.019	0.981	0.000
C38.0 Heart	0.019	0.981	0.000
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)	0.019	0.981	0.000
E05.0 Thyrotoxicosis with diffuse goitre	0.000	0.981	0.019
T80.9 Unspecified complication following infusion, transfusion and therapeutic injection	0.019	0.981	0.000
C80.9 Malignant neoplasm, unspecified	0.019	0.981	0.000
Y60.0 During surgical operation	0.019	0.981	0.000
C32.8 Overlapping lesion of larynx	0.018	0.981	0.000
C32.3 Laryngeal cartilage	0.018	0.981	0.000
C32.2 Subglottis	0.018	0.981	0.000
C91 Lymphoid leukaemia	0.018	0.982	0.000
C79 Secondary malignant neoplasm of other sites	0.018	0.982	0.000
C39.9 Ill-defined sites within the respiratory system	0.018	0.982	0.000
C39.8 Overlapping lesion of respiratory and intrathoracic organs	0.018	0.982	0.000
C39.0 Upper respiratory tract, part unspecified	0.018	0.982	0.000
C48.0 Retroperitoneum	0.018	0.982	0.000
C75 Malignant neoplasm of other endocrine glands and related structures	0.018	0.982	0.000
C71.8 Overlapping lesion of brain	0.017	0.983	0.000
C40 Malignant neoplasm of bone and articular cartilage of limbs	0.017	0.983	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.017	0.983	0.000
C66 Malignant neoplasm of ureter	0.017	0.983	0.000
C68.0 Urethra	0.017	0.983	0.000
C76.8 Overlapping lesion of other and ill-defined sites	0.017	0.983	0.000
C76.7 Other ill-defined sites	0.017	0.983	0.000
C76.5 Lower limb	0.017	0.983	0.000
C76.4 Upper limb	0.017	0.983	0.000
C76.2 Abdomen	0.017	0.983	0.000
C30.1 Middle ear	0.017	0.983	0.000
C71.7 Brain stem	0.017	0.983	0.000
C71.6 Cerebellum	0.017	0.983	0.000
C71.5 Cerebral ventricle	0.017	0.983	0.000
T80.6 Other serum reactions	0.017	0.983	0.000
T80.5 Anaphylactic shock due to serum	0.017	0.983	0.000
T80.4 Rh incompatibility reaction	0.017	0.983	0.000
T80.3 ABO incompatibility reaction	0.017	0.983	0.000
T80.0 Air embolism following infusion, transfusion and therapeutic injection	0.017	0.983	0.000
C41.2 Vertebral column	0.017	0.983	0.000
E07.8 Other specified disorders of thyroid	0.000	0.983	0.017
E05.5 Thyroid crisis or storm	0.000	0.983	0.017
E05.4 Thyrotoxicosis factitia	0.000	0.983	0.017
E05.3 Thyrotoxicosis from ectopic thyroid tissue	0.000	0.983	0.017
C41.9 Bone and articular cartilage, unspecified	0.017	0.983	0.000
C71.3 Parietal lobe	0.017	0.983	0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.017	0.983	0.000
H02.3 Blepharochalasis	0.017	0.983	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.016	0.983	0.000
M20.6 Acquired deformity of toe(s), unspecified	0.016	0.984	0.000
C72.0 Spinal cord	0.016	0.984	0.000
C72.9 Central nervous system, unspecified	0.016	0.984	0.000
C72.8 Overlapping lesion of brain and other parts of central nervous system	0.016	0.984	0.000
C72.5 Other and unspecified cranial nerves	0.016	0.984	0.000
C72.4 Acoustic nerve	0.016	0.984	0.000
C72.3 Optic nerve	0.016	0.984	0.000
C72.2 Olfactory nerve	0.016	0.984	0.000
C72.1 Cauda equina	0.016	0.984	0.000
C41.1 Mandible	0.016	0.984	0.000
C70.9 Meninges, unspecified	0.016	0.984	0.000
C70.1 Spinal meninges	0.016	0.984	0.000
C70.0 Cerebral meninges	0.016	0.984	0.000
C71.0 Cerebrum, except lobes and ventricles	0.016	0.984	0.000
C68.8 Overlapping lesion of urinary organs	0.016	0.984	0.000
C68.1 Paraurethral glands	0.016	0.984	0.000
Y60 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care	0.016	0.984	0.000
C41.0 Bones of skull and face	0.016	0.984	0.000
C41.8 Overlapping lesion of bone and articular cartilage	0.015	0.984	0.000
C41.4 Pelvic bones, sacrum and coccyx	0.015	0.984	0.000
C41.3 Ribs, sternum and clavicle	0.015	0.984	0.000
C30.0 Nasal cavity	0.015	0.984	0.000
C68.9 Urinary organ, unspecified	0.015	0.984	0.000
C79.9 Secondary malignant neoplasm, unspecified site	0.015	0.985	0.000
C76.3 Pelvis	0.015	0.985	0.000
C34.2 Middle lobe, bronchus or lung	0.015	0.985	0.000
C91.5 Adult T-cell leukaemia	0.015	0.985	0.000
C32.1 Supraglottis	0.015	0.985	0.000
C79.7 Secondary malignant neoplasm of adrenal gland	0.015	0.985	0.000
C74.9 Adrenal gland, unspecified	0.015	0.985	0.000
C55 Malignant neoplasm of uterus, part unspecified	0.015	0.985	0.000
C71.9 Brain, unspecified	0.015	0.985	0.000
E05.8 Other thyrotoxicosis	0.000	0.985	0.015
E05.9 Thyrotoxicosis, unspecified	0.000	0.985	0.015
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.015	0.985	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.014	0.985	0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule	0.000	0.985	0.014
C51-C58 Malignant neoplasms of female genital organs	0.014	0.985	0.000
C81.9 Hodgkin's disease, unspecified	0.014	0.986	0.000
M20.5 Other deformities of toe(s) (acquired)	0.014	0.986	0.000
M72.04 Palmar fascial fibromatosis [Dupuytren]-Hand	0.000	0.986	0.014
C73 Malignant neoplasm of thyroid gland	0.014	0.986	0.000
C74.1 Medulla of adrenal gland	0.014	0.986	0.000
C74.0 Cortex of adrenal gland	0.014	0.986	0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.014	0.986	0.000
C42.4 hematopoietic and reticuloendothelial systems: Hematopoietic system, NOS (ICD-O-3 specific)	0.014	0.986	0.000
C42.3 hematopoietic and reticuloendothelial systems: Reticuloendothelial system, NOS (ICD-O-3 specific)	0.014	0.986	0.000
C42.2 hematopoietic and reticuloendothelial systems: spleen (ICD-O-3 specific)	0.014	0.986	0.000
C42.1 hematopoietic and reticuloendothelial systems: bone marrow (ICD-O-3 specific)	0.014	0.986	0.000
C42.0 hematopoietic and reticuloendothelial systems: blood (ICD-O-3 specific)	0.014	0.986	0.000
M20 Acquired deformities of fingers and toes	0.014	0.986	0.000
M20.0 Deformity of finger(s)	0.014	0.986	0.000
C75.0 Parathyroid gland	0.013	0.986	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.013	0.987	0.000
C91.7 Other lymphoid leukaemia	0.013	0.987	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.013	0.987	0.000
C91.3 Prolymphocytic leukaemia	0.013	0.987	0.000
C91.2 Subacute lymphocytic leukaemia	0.013	0.987	0.000
E04 Other non-toxic goitre	0.000	0.987	0.013
C75.9 Endocrine gland, unspecified	0.013	0.987	0.000
C79.2 Secondary malignant neoplasm of skin	0.013	0.987	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.013	0.987	0.000
C75.8 Pluriglandular involvement, unspecified	0.013	0.987	0.000
C75.5 Aortic body and other paraganglia	0.013	0.987	0.000
C75.4 Carotid body	0.013	0.987	0.000
C75.3 Pineal gland	0.013	0.987	0.000
C75.2 Craniopharyngeal duct	0.013	0.987	0.000
C75.1 Pituitary gland	0.013	0.987	0.000
C71.2 Temporal lobe	0.013	0.987	0.000
C50.3 Lower-inner quadrant of breast	0.013	0.987	0.000
C21 Malignant neoplasm of anus and anal canal	0.013	0.987	0.000
Y60.8 During other surgical and medical care	0.013	0.987	0.000
C40.9 Bone and articular cartilage of limb, unspecified	0.012	0.987	0.000
C40.8 Overlapping lesion of bone and articular cartilage of limbs	0.012	0.987	0.000
C40.3 Short bones of lower limb	0.012	0.987	0.000
C40.1 Short bones of upper limb	0.012	0.987	0.000
C40.0 Scapula and long bones of upper limb	0.012	0.987	0.000
M35 Other systemic involvement of connective tissue	0.000	0.987	0.012
C80.0 Malignant neoplasm, primary site unknown, so stated	0.012	0.988	0.000
C91.4 Hairy-cell leukaemia	0.012	0.988	0.000
C15-C26 Malignant neoplasms of digestive organs	0.012	0.988	0.000
I21.1 Acute transmural myocardial infarction of inferior wall	0.000	0.988	0.012
Y60.6 During aspiration, puncture and other catheterisation	0.012	0.988	0.000
T92.0 Sequelae of open wound of upper limb	0.012	0.988	0.000
C21.1 Anal canal	0.012	0.988	0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.012	0.988	0.000
Y60.4 During endoscopic examination	0.012	0.988	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.012	0.988	0.000
Y60-Y69 Misadventures to patients during surgical and medical care	0.012	0.988	0.000
T92.8 Sequelae of other specified injuries of upper limb	0.012	0.988	0.000
C21.8 Overlapping lesion of rectum, anus and anal canal	0.012	0.988	0.000
C91.9 Lymphoid leukaemia, unspecified	0.011	0.988	0.000
Y60.9 During unspecified surgical and medical care	0.011	0.988	0.000
Y60.7 During administration of enema	0.011	0.988	0.000
Y60.5 During heart catheterisation	0.011	0.988	0.000
Y60.3 During injection or immunisation	0.011	0.988	0.000
Y60.2 During kidney dialysis or other perfusion	0.011	0.988	0.000
Y60.1 During infusion or transfusion	0.011	0.988	0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.011	0.989	0.000
C23 Malignant neoplasm of gallbladder	0.011	0.989	0.000
C40.2 Long bones of lower limb	0.011	0.989	0.000
T92 Sequelae of injuries of upper limb	0.011	0.989	0.000
C21.0 Anus, unspecified	0.011	0.989	0.000
C58 Malignant neoplasm of placenta	0.011	0.989	0.000
E04.0 Non-toxic diffuse goitre	0.000	0.989	0.011
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.011	0.989	0.000
C51 Malignant neoplasm of vulva	0.010	0.989	0.000
C91.0 Acute lymphoblastic leukaemia	0.010	0.990	0.000
M35.2 Behcet's disease	0.000	0.990	0.010
T92.9 Sequelae of unspecified injury of upper limb	0.010	0.990	0.000
C22.0 Liver cell carcinoma	0.010	0.990	0.000
C60-C63 Malignant neoplasms of male genital organs	0.010	0.990	0.000
C22.9 Liver, unspecified	0.010	0.990	0.000
C17 Malignant neoplasm of small intestine	0.010	0.990	0.000
E04.8 Other specified non-toxic goitre	0.000	0.990	0.010
Z42.1 Follow-up care involving plastic surgery of breast	0.010	0.990	0.000
C83.6 Undifferentiated (diffuse)	0.010	0.990	0.000
C83.5 Lymphoblastic (diffuse)	0.010	0.990	0.000
C83.4 Immunoblastic (diffuse)	0.010	0.990	0.000
C83.2 Mixed small and large cell (diffuse)	0.010	0.990	0.000
T92.1 Sequelae of fracture of arm	0.010	0.990	0.000
C21.2 Cloacogenic zone	0.009	0.990	0.000
C26 Malignant neoplasm of other and ill-defined digestive organs	0.009	0.991	0.000
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.009	0.991	0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre	0.000	0.991	0.009
C77.9 Lymph node, unspecified	0.009	0.991	0.000
Y66 Nonadministration of surgical and medical care	0.009	0.991	0.000
M35.9 Systemic involvement of connective tissue, unspecified	0.000	0.991	0.009
M35.6 Relapsing panniculitis [Weber-Christian]	0.000	0.991	0.009
M35.5 Multifocal fibrosclerosis	0.000	0.991	0.009
M35.4 Diffuse (eosinophilic) fasciitis	0.000	0.991	0.009
C83.1 Small cleaved cell (diffuse)	0.009	0.991	0.000
M20.1 Hallux valgus (acquired)	0.009	0.991	0.000
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.009	0.991	0.000
C19 Malignant neoplasm of rectosigmoid junction	0.009	0.991	0.000
Y61 Foreign object accidentally left in body during surgical and medical care	0.009	0.991	0.000
C57 Malignant neoplasm of other and unspecified female genital organs	0.009	0.991	0.000
M35.1 Other overlap syndromes	0.000	0.991	0.009
M35.7 Hypermobility syndrome	0.000	0.991	0.009
Y64 Contaminated medical or biological substances	0.009	0.991	0.000
Y63 Failure in dosage during surgical and medical care	0.009	0.991	0.000
Y62 Failure of sterile precautions during surgical and medical care	0.009	0.991	0.000
Y69 Unspecified misadventure during surgical and medical care	0.009	0.991	0.000
M20.2 Hallux rigidus	0.009	0.991	0.000
Y65 Other misadventures during surgical and medical care	0.009	0.991	0.000
T92.4 Sequelae of injury of nerve of upper limb	0.008	0.992	0.000
C50.2 Upper-inner quadrant of breast	0.008	0.992	0.000
C22.7 Other specified carcinomas of liver	0.008	0.992	0.000
C22.4 Other sarcomas of liver	0.008	0.992	0.000
C22.3 Angiosarcoma of liver	0.008	0.992	0.000
C22.2 Hepatoblastoma	0.008	0.992	0.000
C77.2 Intra-abdominal lymph nodes	0.008	0.992	0.000
Z12.1 Special screening examination for neoplasm of intestinal tract	0.008	0.992	0.000
M35.8 Other specified systemic involvement of connective tissue	0.000	0.992	0.008
C83.7 Burkitt's tumour	0.008	0.992	0.000
C17.2 Ileum	0.008	0.992	0.000
C54 Malignant neoplasm of corpus uteri	0.008	0.992	0.000
C77.1 Intrathoracic lymph nodes	0.008	0.992	0.000
C17.9 Small intestine, unspecified	0.008	0.992	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.008	0.992	0.000
C85.0 Lymphosarcoma	0.008	0.992	0.000
C51.8 Overlapping lesion of vulva	0.008	0.992	0.000
C51.2 Clitoris	0.008	0.992	0.000
C51.1 Labium minus	0.008	0.992	0.000
C51.0 Labium majus	0.008	0.992	0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.007	0.992	0.000
C83.3 Large cell (diffuse)	0.008	0.992	0.000
C51.9 Vulva, unspecified	0.008	0.992	0.000
C53 Malignant neoplasm of cervix uteri	0.007	0.992	0.000
Chapter XX External causes of morbidity and mortality	0.008	0.992	0.000
C26.9 Ill-defined sites within the digestive system	0.007	0.992	0.000
C91.1 Chronic lymphocytic leukaemia	0.008	0.992	0.000
M20.4 Other hammer toe(s) (acquired)	0.008	0.992	0.000
C60 Malignant neoplasm of penis	0.007	0.992	0.000
T92.5 Sequelae of injury of muscle and tendon of upper limb	0.007	0.993	0.000
C63 Malignant neoplasm of other and unspecified male genital organs	0.007	0.993	0.000
C17.8 Overlapping lesion of small intestine	0.007	0.993	0.000
C17.3 Meckel's diverticulum	0.007	0.993	0.000
C17.0 Duodenum	0.007	0.993	0.000
H02.4 Ptosis of eyelid	0.007	0.993	0.000
C22.1 Intrahepatic bile duct carcinoma	0.007	0.993	0.000
T92.6 Sequelae of crushing injury and traumatic amputation of upper limb	0.007	0.993	0.000
C24.9 Biliary tract, unspecified	0.007	0.993	0.000
Y86 Sequelae of other accidents	0.007	0.993	0.000
M72.0 Palmar fascial fibromatosis [Dupuytren]	0.000	0.993	0.007
C24.0 Extrahepatic bile duct	0.007	0.993	0.000
Y61.0 During surgical operation	0.007	0.993	0.000
C43-C44 Melanoma and other malignant neoplasms of skin	0.007	0.993	0.000
V70-V79 Bus occupant injured in transport accident	0.007	0.993	0.000
C26.8 Overlapping lesion of digestive system	0.007	0.993	0.000
C26.1 Spleen	0.007	0.993	0.000
M20.3 Other deformity of hallux (acquired)	0.007	0.993	0.000
C24.8 Overlapping lesion of biliary tract	0.007	0.993	0.000
K14.8 Other diseases of tongue	0.000	0.993	0.007
X40-X49 Accidental poisoning by and exposure to noxious substances	0.007	0.993	0.000
M35.99 Systemic involvement of connective tissue, unspecified, Site unspecified	0.000	0.993	0.007
W75-W84 Other accidental threats to breathing	0.007	0.993	0.000
C57.9 Female genital organ, unspecified	0.007	0.993	0.000
Y61.9 During unspecified surgical and medical care	0.007	0.993	0.000
Y61.8 During other surgical and medical care	0.007	0.993	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations